Pitfalls in the Valuation of a Pharmaceutical Company

[PDF] researchgate.net

[PDF][PDF] Evaluation and valuation of the price of expensive medicinal products: application of the discounted cash flow to orphan drugs

M Nuijten, HJ Fugel, J Vis - Int J Rare Dis Disord, 2018 - researchgate.net
Background Many pharmaceutical companies are now commercialising innovative so-called
expensive medicinal products with incremental cost-effectiveness ratios (ICERs), which …
Save Cite Cited by 4 Related articles All 2 versions View as HTML